| Date Filed | Type | Description |
| 03/29/2018 |
SC 13G
| MILLENNIUM PHARMACEUTICALS INC reports a 12.2% stake in Myovant Sciences Ltd. |
| 02/11/2009 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/09/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
| 05/14/2008 |
8-K
| Quarterly results |
| 05/12/2008 |
10-Q
| Quarterly Report for the period ended March 31, 2008 |
| 04/15/2008 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...|
Docs:
|
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Deborah Dunsire",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Christophe Bianchi",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Marsha Fanucci",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Laurie Keating",
"Amendment to Letter Agreement, between Millennium Pharmaceuticals, Inc. and Nancy Simonian" |
|
| 04/10/2008 |
8-K
| Results of Operations and Financial Condition |
| 04/10/2008 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...|
Docs:
|
"Agreement and Plan of Merger, among Takeda American Holdings, Inc., Mahogany Acquisition Corp. and Millennium Pharmaceuticals, Inc.",
"Amendment, to the Rights Agreement, between Millennium Pharmaceuticals, Inc. and Computershare Trust Company, N.A. (as successor Rights Agent to State Street Bank and Trust Company), as rights agent",
"TAKEDA TO ACQUIRE MILLENNIUM FOR US$25.00 PER SHARE IN AN ALL CASH TENDER OFFER VALUED AT $8.8 BILLION" |
|
| 04/07/2008 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/07/2008 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 02/29/2008 |
10-K
| Annual Report for the period ended December 31, 2007 |
| 02/29/2008 |
8-K
| Regulation FD Disclosure |
| 02/07/2008 |
8-K
| Results of Operations and Financial Condition |
| 02/07/2008 |
TRN
| Millennium Pharmaceuticals, Inc. Q4 2007 Earnings Call Transcript |
| 01/07/2008 |
TRN
| Millennium Pharmaceuticals 2008 Guidance Call Transcript |
| 01/04/2008 |
8-K
| Results of Operations and Financial Condition |
| 11/09/2007 |
10-Q
| Quarterly Report for the period ended September 30, 2007 |
| 11/01/2007 |
8-K
| Results of Operations and Financial Condition |
| 11/01/2007 |
TRN
| Millennium Pharmaceuticals Q3 2007 Earnings Call Transcript |
| 10/05/2007 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
| 08/08/2007 |
10-Q
| Quarterly Report for the period ended June 30, 2007 |
| 07/26/2007 |
8-K
| Results of Operations and Financial Condition |
| 07/26/2007 |
TRN
| Millennium Pharmaceuticals Q2 2007 Earnings Call Transcript |
| 05/10/2007 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Amendments to Article... |
| 05/09/2007 |
10-Q
| Quarterly Report for the period ended March 31, 2007 |
| 04/26/2007 |
8-K
| Results of Operations and Financial Condition |
| 04/26/2007 |
TRN
| Millennium Pharmaceuticals Q1 2007 Earnings Call Transcript |
| 03/28/2007 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements |
| 03/13/2007 |
8-K
| Other Events |
| 03/01/2007 |
10-K
| Annual Report for the period ended December 31, 2006 |
| 02/08/2007 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Principal Officers; Election of Directors; Appointme... |
| 01/29/2007 |
5
| Form 5 -- Annual statement of changes in beneficial ownership of securities |
| 01/04/2007 |
8-K
| Results of Operations and Financial Condition |
| 12/14/2006 |
8-K
| Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers |
|